HeartBeam Corporation - BEAT Quarterly EPS earnings growth

HeartBeam, Inc. (BEAT) - corporate logo

HeartBeam, Inc. (BEAT) is shielded by domestic US demand but remains dependent on global chip supplies. The company is building a remote cardiology network through cloud integration of 3D-ECG. As the project currently awaits FDA approval, the stock valuation remains venture-like. The quarterly percentage growth in earnings per share reflects the business dynamics, where the indicator value stands at 65.30.

heartbeam.com (BEAT) - Earnings per share growth in annualized terms for the last twelve months from 07/04/2022 to 11/14/2026

Analytical breakdowns and data insights for company HeartBeam (BEAT)

- share price and consensus valuation forecast:
Stock Quotes HeartBeam|BEAT - Analyst Forecast Prices
- issuer market value details:
Market Capitalization HeartBeam|BEAT - Total Company Value
- balance sheet net asset value indicators:
Book Value per Share HeartBeam|BEAT - Total Stockholders' Equity|Market Capitalization to Book Value Ratio heartbeam.com|BEAT - Company Total Assets
- debt burden and liquidity indicators:
Debt to Equity HeartBeam, Inc.|BEAT - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio HeartBeam|BEAT - Aggregate Debt Obligations|Debts to Book Capitalization HeartBeam Inc|BEAT - Long-Term Debt Volume|Company Short-Term Debt HeartBeam|Quick Ratio heartbeam.com
- earnings and valuation multiples indicators:
BEAT - Net Income|Future Profit HeartBeam, Inc.|BEAT - Business Payback Period|Forward P/E Multiple HeartBeam, Inc.|BEAT - Price/Earnings to Growth Ratio|EV/EBITDA Multiple HeartBeam Corp|BEAT - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) HeartBeam|BEAT - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months heartbeam.com|BEAT - Net earnings per one share growth for the current year|Earnings growth forecast for next year HeartBeam, Inc.
- sales volume and revenue indicators:
BEAT - Company Sales Revenue|Projected Sales Volume heartbeam.com|BEAT - Price to Sales|Forward P/S Multiple HeartBeam Corporation
Summary company analytics:HeartBeam Corporation - BEAT
Manufactured product of heartbeam.com

Earnings per share dynamics measure the pace of net income generation, reflecting real operational efficiency and the business's ability to scale margins. A stable quarterly EPS trend confirms the maturity of HeartBeam, Inc., whose resilience to macroeconomic shocks is ensured by constant demand for medical services, making this indicator a reliable filter for assessing long-term capital potential.

Competitors of HeartBeam, Inc. (BEAT)

Regeneron Pharmaceuticals (REGN) - Year-over-year earnings per share growth for the last twelve months|IRTC: Year-over-year earnings per share growth rate for the last twelve months|LNTH (Lantheus Holdings) - Quarterly EPS earnings growth|Quarterly EPS earnings growth mineralystx.com|Year-over-year earnings per share growth for the last twelve months HeartFlow Inc (HTFL)|KMTS (Kestra Medical Technologies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Esperion Therapeutics ESPR|AMRN - Year-over-year net earnings per share growth for the last 12 months|Anteris Technologies Ltd - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TNYA (tenayatherapeutics.com)|CVRX: Quarterly EPS earnings growth|Milestone Pharmaceuticals, Inc. - Year-over-year earnings per one share growth for the last 12 months|CRDL (Cardiol Therapeutics Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Tenax Therapeutics Inc|Quarterly EPS earnings growth ADGM|BioCardia, Inc. - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth VTAK (Catheter Precision Inc)|ABIO - Year-over-year net earnings per share growth for the last 12 months|Acasti Pharma - Quarterly EPS earnings growth|AVTE - Quarterly EPS earnings growth|VERV (vervetx.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share trend for the last twelve months WINT (Windtree Therapeutics Inc.)